Texas Oncology-Dallas Presbyterian Hospital is a clinical research site located in Dallas, Texas, United States 75231.
Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology-Dallas Presbyterian Hospital has participated in 38 clinical trials with 13 currently active.
Therapeutic areas: Pancreatic Adenocarcinoma, HER2-Positive Early Breast Cancer, Non-small Cell Lung Cancer.
Sponsors: ImmunoGenesis, Hoffmann-La Roche, Effector Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Dallas
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology-Dallas Presbyterian Hospital has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology-Dallas Presbyterian Hospital has 38 clinical trials on record, with 13 currently active. Their work covers Pancreatic Adenocarcinoma, HER2-Positive Early Breast Cancer, Non-small Cell Lung Cancer.
Texas Oncology-Dallas Presbyterian Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.